The FDA has approved secukinumab (Cosentyx; Novartis) for the treatment of pediatric patients 12 years and older with moderate to severe hidradenitis suppurativa (HS), the company announced. 1 The ...

US FDA approves Novartis Cosentyx for paediatric patients aged 12+ with moderate to severe hidradenitis suppurativa: Basel Monday, March 16, 2026, 14:00 Hrs [IST] Novartis announc ...

The clash over EV charging money and Clean Air Act protections highlights a broader decision point for the country. One path speeds the shift to cleaner vehicles and offers some relief for communities ...

Dozens of Telegram channels reviewed by WIRED include job listings for “AI face models.” The (mostly) women who land these ...

Two parallel experiments in protein self-assembly produced strikingly different results, demonstrating that protein designers ...

A new platform lets athletes license their biometric data and digital likenesses to AI developers, creating a royalty system ...

With support from Advisory Council Kelly Kimball and SDCIE Kristin Bell, two of Kristin's teams were among the top 10 startups that were honored as winners at Startup India.

A new computational tool infers changes occurring at the ends of the chromosomes housing our DNA. It does so by detecting ...

Our Kingsmen and Regals compete firecely in NCAA Division III athletics. Immerse yourself in our beautiful campus where there's something for everyone. At Cal Lutheran, you'll find a dedicated and ...

First Proof is an effort to see whether LLMs can contribute meaningfully to pure mathematics research. The dust has settled on round one, and the results are surprising ...

Nvidia Corp. today stoked the fires of the emerging artificial intelligence factory trend with the announcement of Dynamo 1.0, an open-source platform the company is positioning as an essential ...